| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
Nuformix kicks of studies on pipeline assets following fundraising
StockMarketWire.com
|
Drug repurposing group Nuformix said it had started planned studies on its pipeline assets; a new form of tranilast and an undisclosed oncology drug.
Commencement of the work on the assets, NXP002 and NXP004, followed completion of a recent fundraising. For NXP002, an additional pre-clinical activities on inhalation feasibility data package had commenced.
For NXP004, additional research was being undertaken into new physical forms.
At 8:49am: (LON:NFX) Nuformix Plc share price was 0p at 2.95p
Story provided by StockMarketWire.com
|
|
|
|
|
|
